EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).

• Lam TBL Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK. Electronic address: thomas.lam@nhs.net.
• MacLennan S Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
• Willemse PM Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
• Mason MD Division of Cancer and Genetics, School of Medicine Cardiff University, Velindre Cancer Centre, Cardiff, UK.
• Plass K EAU Guidelines Office, Arnhem, The Netherlands.
• Shepherd R EAU Guidelines Office, Arnhem, The Netherlands.
• Baanders R Oxford, UK.
• Bangma CH Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
• Bjartell A Department of Urology, Skåne University Hospital Malmö, Lund University, Lund, Sweden.
• Bossi A Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
• Briers E Hasselt, Belgium.
• Briganti A Department of Urology, Scientific Institute and University Vita-Salute San Raffaele Hospital, Milan, Italy.
• Buddingh KT HagaZiekenhuis, The Hague, The Netherlands.
• Catto JWF Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
• Colecchia M Uropathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
• Cox BW Department of Radiation Medicine, Zucker School of Medicine, Hempstead, New York, NY, USA.
• Cumberbatch MG Academic Urology Unit, University of Sheffield, Sheffield, UK.
• Davies J Wales, UK.
• Davis NF Department of Urology, Beaumont and Connolly Hospitals, Dublin, Ireland; Royal College of Surgeons in Ireland, Dublin, Ireland.
• De Santis M Department of Urology, Charité University Hospital, Berlin, Germany.
• Dell'Oglio P Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; ORSI Academy, Melle, Belgium.
• Deschamps A Europa Uomo, Antwerp, Belgium.
• Donaldson JF Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
• Egawa S Asian School of Urology, UAA, Jikei University School of Medicine, Tokyo, Japan.
• Fankhauser CD Department of Urology, University of Zurich, Zurich, Switzerland.
• Fanti S Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Italy.
• Fossati N Department of Urology, Scientific Institute and University Vita-Salute San Raffaele Hospital, Milan, Italy.
• Gandaglia G Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
• Gillessen S Division of Cancer Sciences, University of Manchester and The Christie, Manchester, UK; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, University of Bern, Bern, Switzerland.
• Grivas N Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• Gross T Department of Urology, University of Bern, Bern, Switzerland.
• Grummet JP Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.
• Henry AM Leeds Cancer Centre, St. James's University Hospital, Leeds, UK.
• Ingels A Department of Urology, Henri Mondor Hospital, Créteil, France.
• Irani J University Hospital of Bicêtre-Paris Sud-Saclay University, Le Kremlin Bicêtre, France.
• Lardas M Department of Reconstructive Urology and Surgical Andrology, Metropolitan General, Athens, Greece.
• Liew M Department of Urology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
• Lin DW Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Urology, University of Washington, Seattle, WA, USA.
• Moris L Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
• Omar MI Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
• Pang KH Academic Urology Unit, University of Sheffield, Sheffield, UK.
• Paterson CC Academic Urology Unit, University of Aberdeen, Aberdeen, UK; University of Canberra, School of Nursing, Midwifery and Public Health, Canberra, Australia; Robert Gordon University, School of Nursing and Midwifery, Aberdeen, UK.
• Renard-Penna R Academic Department of Radiology, Sorbonne Université, GRC no 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière-Hôpital Tenon, Paris, France.
• Ribal MJ Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
• Roobol MJ Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
• Rouprêt M Urology Department, Sorbonne Université, GRC no 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
• Rouvière O Hospices Civils de Lyon, Department of Urinary and Vascular Imaging, Hôpital Edouard Herriot, Lyon, France; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.
• Sancho Pardo G Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• Richenberg J Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School, Brighton, Sussex, UK.
• Schoots IG Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
• Sedelaar JPM Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
• Stricker P Department of Urology, St Vincents Hospital and Campus, Sydney, Australia; Garvan Institute of Research, Sydney, Australia.
• Tilki D Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
• Vahr Lauridsen S Department of Urology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
• van den Bergh RCN Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.
• Van den Broeck T Department of Urology, University Hospitals Leuven, Leuven, Belgium.
• van der Kwast TH Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• van der Poel HG Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• van Leenders GJLH Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• Varma M Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.
• Violette PD Departments of Health Research Methods, Evidence and Impact (HEI) and Surgery, McMaster University, Hamilton, ON, Canada.
• Wallis CJD Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
• Wiegel T Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
• Wilkinson K University College London Hospitals, London, UK.
• Zattoni F Urology Unit, Academic Medical Centre Hospital, Udine, Italy.
• N'Dow JMO Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
• Van Poppel H Department of Urology, University Hospitals Leuven, Leuven, Belgium.
• Cornford P Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
• Mottet N Department of Urology, University Hospital Jean Monnet, St. Etienne, France.

Show more…

Active surveillance and monitoring

Clinical practice guidelines

Consensus group meeting

Consensus statements

Deferred treatment with curative intent

Delphi survey

Eligibility

Follow-up

Localised prostate cancer

Outcome measures

Reclassification